本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Olema Pharmaceuticals, Inc.

5.16
+0.12002.38%
成交量:70.72萬
成交額:363.30萬
市值:3.53億
市盈率:-2.34
高:5.25
開:4.98
低:4.95
收:5.04
資料載入中...
2024/12/10

重要事件披露

Form 8-K - Current report
2024/12/04

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/02

重要事件披露

Form 8-K - Current report
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/09/27

重要事件披露

Form 8-K - Current report
2024/08/06

重要事件披露

Form 8-K - Current report
2024/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/02

重要事件披露

Form 8-K - Current report
2024/06/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/14

重要事件披露

Form 8-K - Current report
2024/06/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/06/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/06

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]